Evaluation of the effects of Rosuvastatin in the treatment of patients with deep vein thrombosis(DVT)
Phase 3
- Conditions
- Deep Vein Thrombosis.Phlebitis and thrombophlebitis of other deep vessels of lower extremities
- Registration Number
- IRCT20150621022852N4
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
All patients with unilateral Deep Vein thrombosis of the lower extremities.
Exclusion Criteria
Patients with ESRD who underwent regular dialysis and patients with CRF who had GFR below 1.73 m2.mL / min
Patients need any invasive intervention in the treatment of DVT.
The patient with any illness, including infection and sepsis, which can interfere with the level of inflammatory factors and D-dimer.
Patients with history of active malignancy.
Bilateral lower limb DVT
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of post thrombotic phlebitis syndrome. Timepoint: After three months from the start of the study. Method of measurement: Based on clinical criteria according to Brandjes questionnaire.
- Secondary Outcome Measures
Name Time Method Serum levels of C-reactive protein, D-Dimer, as well as lower limb size. Timepoint: At the end of the third month of study. Method of measurement: Using serum samples to measure serum CRP and D-dimer levels, as well as instrumentation for measuring lower limb size.